2-(Ethylamino)-1,2-diphenylethanone

Chemical compound vanc 2-(ethylamino)-1,2-diphenylethanone ΒK-Ephinidine.svg skin-invert-image 200px correct CAS 22312-16-9 correct FDA 8R3EAH84GZ None 69702363 129327880 16 17 1 1 CCNC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2 1S/C16H17NO/c1-2-17-15(13-9-5-3-6-10-13)16(18)14-11-7-4-8-12-14/h3-12,15,17H,2H2,1H3 NHNVMSYWZNJBOO-UHFFFAOYSA-N 2-(Ethylamino)-1,2-diphenylethanone (also known as α-ethylamino-deoxybenzoin, [α-(Ethylamino)benzyl]-(phenyl)-ketone and βk-Ephenidine) is a chemical compound which was first invented in 1955, Hinderling R, Prijs B, Erlenmeyer H Über α-Alkylamino-ketone. Helvetica Chimica Acta 1955 38 6 1415–1420 10.1002/hlca.19550380613 researched by ICI in 1969 as an antidepressant, GB 1143263 Gilman DJ ICI Ltd. Desyl amines and compositions thereof. gdate = 19 February 1969 and subsequently claimed by AstraZeneca as an inhibitor of the enzyme 11β-Hydroxysteroid dehydrogenase type 1. US 2005272036 Barton P, Clarke D, Davies C, Hargreaves R, Pease J, Rankine M AstraZeneca AB Abandoned 8 December 2005 Ketones No other pharmacological data has been disclosed, though its chemical structure closely resembles that of certain designer drug compounds such as ephenidine and N-ethylhexedrone. See also α-PCYP Alpha-D2PV Fluorolintane Indapyrophenidone Lefetamine UWA-001 References Category:Enzyme inhibitors Category:Drugs developed by AstraZeneca Category:Benzaldehydes Category:Phenethylamines